Blog
RSS FeedPosted by Michael Wonder on 18 Oct 2024
PHARMAC seeking bids from suppliers for COVID-19 vaccines
17 October 2024 - PHARMAC is seeking bids from pharmaceutical suppliers of COVID-19 vaccines. ...
Posted by Michael Wonder on 05 May 2024
PHARMAC and Health NZ weigh up future of COVID-19 vaccines and treatments
3 May 2024 - PHARMAC and Health NZ are weighing up the future direction of COVID-19 vaccinations and treatments in ...
Posted by Michael Wonder on 22 Feb 2024
COVID-19 vaccine available in March
22 February 2024 - Joint media release with Health New Zealand. ...
Posted by Michael Wonder on 21 Dec 2023
Future supply of new COVID-19 vaccines confirmed
20 December 2023 - A vaccine to combat the newer strains of COVID-19 has been approved and will be available ...
Posted by Michael Wonder on 07 Dec 2023
Evolving our approach to COVID-19 vaccines and treatments
6 December 2023 - As New Zealand’s response to the COVID-19 pandemic has evolved, so has ours. ...
Posted by Michael Wonder on 20 Sep 2023
Access to COVID-19 anti-viral treatments widened for more people at risk
20 September 2023 - PHARMAC is widening access to COVID-19 anti-virals to people who are vulnerable to severe infection from ...
Posted by Michael Wonder on 18 Sep 2023
COVID-19 vaccine contract summary
18 September 2023 - The Ministry of Health has released a summary of the New Zealand Government’s procurement process for ...
Posted by Michael Wonder on 16 Aug 2023
PHARMAC calls for applications from the suppliers of vaccines that protect against COVID-19
16 August 2023 - PHARMAC is interested to hear from pharmaceutical suppliers who manufacture vaccines that protect against COVID-19 and ...
Posted by Michael Wonder on 01 Aug 2023
PHARMAC considers access criteria for COVID-19 anti-viral treatments
1 August 2023 - PHARMAC is consulting on changes to the access criteria for all COVID-19 anti-viral treatments to include ...
Posted by Michael Wonder on 27 Jul 2023
Molnupiravir will remain available for people who need it
27 July 2023 - PHARMAC has confirmed today that molnupiravir will remain available as a treatment to protect against infection ...
Posted by Michael Wonder on 04 Apr 2023
PHARMAC seeking feedback on the COVID-19 anti-viral molnupiravir
4 April 2023 - PHARMAC are consulting on the role of molnupiravir in New Zealand’s portfolio of COVID-19 treatments. ...
Posted by Michael Wonder on 12 Sep 2022
PHARMAC simplifies criteria for COVID-19 anti-viral treatments
12 September 2022 - PHARMAC has confirmed today that it is simplifying the access criteria for the three anti-viral treatments it ...
Posted by Michael Wonder on 26 Aug 2022
Government secures monkeypox medicine, PHARMAC working on getting vaccines
26 August 2022 - The Government has secured monkeypox medicine which is expected to be available in New Zealand from ...
Posted by Michael Wonder on 24 Aug 2022
Access criteria for new COVID-19 treatment announced
25 August 2022 - PHARMAC has today confirmed the access criteria for the first preventative medicine for COVID-19, tixagevimab and cilgavimab ...
Posted by Michael Wonder on 06 Aug 2022
New Zealand allowed pharmacists to dispense COVID-19 antivirals and 'everyone realised it was a win'
6 August 2022 - With Australians dying from COVID-19 every day and nearly 5,000 people in hospital with the disease, experts ...